You have access
Efficacy of Ramucirumab Versus Sorafenib as Subsequent Treatment for Hepatocellular Carcinoma
KAZUKI MAESAKA, RYOTARO SAKAMORI, RYOKO YAMADA, YUKI TAHATA, KAZUYOSHI OHKAWA, MASAHIDE OSHITA, SHINJI TAMURA, HIDEKI HAGIWARA, EIJI MITA, TAKAYUKI YAKUSHIJIN, MASAMI INADA, TAKAHIRO KODAMA, HAYATO HIKITA, TOMOHIDE TATSUMI and TETSUO TAKEHARA
Anticancer Research April 2021, 41 (4) 2187-2192; DOI: https://doi.org/10.21873/anticanres.14993